Page 2 - Nova Lima News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Afya : Unaudited interim condensed consolidated financial statements - Form 6-K

Afya : Unaudited interim condensed consolidated financial statements - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Porto velhoRio de janeiroEstado do rioMontes clarosMinas geraisPato brancoEstado de pernambucoRibeira do pombalNova limaDuque de caxiasEl salvadorOporto nacionalSociedade padrSistemas computacionais ltdaCentro universitCaxias ltda

JBS S A : MINUTES OF THE ANNUAL AND EXTRAORDINARY SHAREHOLDERS MEETING HELD ON APRIL 26, 2024 - Form 6-K

MINUTES OF THE ANNUAL AND EXTRAORDINARY SHAREHOLDERS MEETING HELD ON APRIL 26, 2024 Date, Time, and Venue: April 26, 2024, at 10:00 a.m., at the headquarters of JBS S.A.,.

Pontese lacerdaEstado de mato grossoUnited statesMethodist hospitalUnited kingdom generalUnited kingdomChicago schoolSouth australiaSanto antonioEspíto santoNorth yorkshireRio grande do norteRio grande do sulMinas geraisFazenda canadaStanislaus county

Brazil opens insulin-producing plant

Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin-producing plant. The Government will purchase the entire output to make it available free of charge nationwide for diabetes patients. The facility is said to have cost around R$ 800 million (US$ 156 million) through loans from public banks. The South American country currently imports 95% of the insulin it uses. Some 15.7 million adults are said to have the malady nationwide.

United statesMinas geraisNova limaOswaldo cruz foundation fiocruzSilva fridaySouth americanAna luaOswaldo cruz foundationNational strategyHealth economic industrial complex

Biocon signs agreement with Biomm for generic Semaglutide commercialisation in Brazil

Biocon signs agreement with Biomm for generic Semaglutide commercialisation in Brazil
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Nova limaMinas geraisSiddharth mittalHeraldo marcheziniInternational diabetes federationChief executive officerManaging directorDiabetes atlas

Biocon signs licensing and supply deal for diabetes drug in Brazil

Biocon, an India-based biopharmaceutical company, has entered into an exclusive licensing and supply agreement with Brazilian specialty pharmaceutical company Biomm for the commercialisation of Semaglutide (gOzempic), a drug used to improve glycemic control in adults with type-2 diabetes.

Nova limaMinas geraisSiddharth mittalHeraldo marcheziniInternational diabetes federationDiabetes atlas